Differential prognostic impact of favourable prostate cancer pathology risk score patterns predicted by Briganti’s 2012 nomogram across EAU risk groups: Analysis of 757 cases treated with robotic surgery
Differential prognostic impact of favourable prostate cancer pathology risk score patterns predicted by Briganti’s 2012 nomogram across EAU risk groups: Analysis of 757 cases treated with robotic surgery
(2025)
Differential prognostic impact of favourable prostate cancer pathology risk score patterns predicted by Briganti’s 2012 nomogram across EAU risk groups: Analysis of 757 cases treated with robotic surgery
Anno:
2025
Tipologia prodotto:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Lingua:
Inglese
Referee:
Sì
Nome rivista:
CENTRAL EUROPEAN JOURNAL OF UROLOGY
ISSN Rivista:
2080-4806
N° Volume:
78
Numero o Fascicolo:
2
Intervallo pagine:
109-115
Parole chiave:
prostate cancer; EAU risk classes; prostate cancer nomograms; robot assisted radical prostatectomy; favorable prostate cancer pathology; prostate cancer progression
Breve descrizione dei contenuti:
Introduction The aim of this study was to evaluate the prognostic impact of favourable prostate cancer
(PCa) pathology patterns through Briganti’s 2012 nomogram and beyond EAU risk classes in patients
treated with robotic surgery.
Material and methods We analysed 757 patients from January 2013 to December 2021 with favourable
pathology features (ISUP 1-3, pT2/pT3a, and pN0/x) and available follow-up. Pathologic features were
scored from zero (ISUP 1 + pT2) to three (ISUP 3 + pT3a). Associations with Briganti’s 2012 nomogram
by EAU risk class were evaluated to determine the prognostic impact on PCa progression, defined
as biochemical persistence/recurrence or loco-regional/metastatic recurrence.
Results Favourable pathology risk scores were most commonly grades one (49%) and two (30.95%),
followed by zero (15.2%) and three (4.9%). After adjusting for EAU prognostic groups, higher nomogram
scores were associated with increased risk scores of two and three. PCa progression occurred in 12.7%
of cases after a mean follow-up of 92.1 months. Patients with recurrence had a worse prognosis as risk
scores increased from one to three, even after adjustment for Briganti’s 2012 nomogram by EAU class.
Conclusions Favourable pathology risk scores, grouped by Briganti’s 2012 and EAU nomograms, impact
prognosis. As scores increase, the likelihood of disease progression rises, potentially influencing treatment
strategies.